Medicare Enrolled
Dr. Nader Warra, D.O.
Neurology · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Warra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Warra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Warra
Dr. Nader Warra is a neurology specialist in Farmington Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Warra performed 1,568 Medicare services across 1,195 unique beneficiaries.
Between the years covered by Open Payments, Dr. Warra received a total of $136,462 from 80 pharmaceutical and/or device companies across 1555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Warra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in MI
$136,462 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,568
Medicare services
Top 10% in MI for neurology
1,195
Unique beneficiaries
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~83 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $95 | $155 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
208 | $86 | $218 |
| New patient office visit, complex (60-74 min) | 153 | $165 | $290 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
147 | $356 | $870 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
120 | $136 | $205 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
72 | $223 | $585 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
71 | $27 | $75 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
70 | $27 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $144 | $280 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
21 | $172 | $450 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
17 | $109 | $290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$136,462
Total received (2018-2024)
Avg $19,495/year across 7 years
Top 7% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,555
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109,608 (80.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,305 (14.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,549 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$29,374
2023
$13,687
2022
$3,181
2021
$20,099
2020
$9,361
2019
$36,664
2018
$24,097
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$11,894
Lilly USA, LLC
$7,699
Takeda Pharmaceuticals U.S.A., Inc.
$6,115
EMD Serono, Inc.
$518
UCB, Inc.
$417
ABBVIE INC.
$356
Lundbeck LLC
$290
Novartis Pharmaceuticals Corporation
$276
Biogen, Inc.
$272
Neurocrine Biosciences, Inc.
$241
Alexion Pharmaceuticals, Inc.
$196
Alnylam Pharmaceuticals Inc.
$153
Celgene Corporation
$134
Sumitomo Pharma America, Inc.
$129
E.R. Squibb & Sons, L.L.C.
$122
Genentech USA, Inc.
$78
CSL Behring
$78
CATALYST PHARMACEUTICALS, INC.
$72
Amgen Inc.
$54
ARGENX US, INC.
$44
ACADIA Pharmaceuticals Inc
$44
Teva Pharmaceuticals USA, Inc.
$33
SK Life Science, Inc.
$33
Grifols USA, LLC
$27
Octapharma USA, Inc.
$24
LivaNova USA, Inc.
$21
Otsuka America Pharmaceutical, Inc.
$19
JAZZ PHARMACEUTICALS INC.
$19
Aucta Pharmaceuticals, Inc.
$14
Top 3 companies account for 87.5% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$31,237
GENZYME CORPORATION
$19,909
US WorldMeds, LLC
$13,488
Avanir Pharmaceuticals, Inc.
$13,045
Eisai Inc.
$12,331
Biogen, Inc.
$9,774
Lilly USA, LLC
$8,011
Takeda Pharmaceuticals U.S.A., Inc.
$6,197
Corium, LLC
$4,098
Novartis Pharmaceuticals Corporation
$2,384
EMD Serono, Inc.
$2,212
MDD US Operations, LLC
$1,603
UCB, Inc.
$1,472
Celgene Corporation
$870
Amgen Inc.
$836
Neurocrine Biosciences, Inc.
$672
CSL Behring
$616
AbbVie Inc.
$604
Alexion Pharmaceuticals, Inc.
$516
ABBVIE INC.
$510
Lundbeck LLC
$492
Acorda Therapeutics, Inc
$441
Genentech USA, Inc.
$315
Alnylam Pharmaceuticals Inc.
$303
Grifols USA, LLC
$272
ACADIA Pharmaceuticals Inc
$246
Supernus Pharmaceuticals, Inc.
$222
E.R. Squibb & Sons, L.L.C.
$205
AbbVie, Inc.
$199
Adamas Pharmaceuticals, Inc.
$187
Sumitomo Pharma America, Inc.
$187
EISAI INC.
$170
Biohaven Pharmaceuticals, Inc.
$166
Allergan Inc.
$162
PFIZER INC.
$161
Horizon Therapeutics plc
$160
Validus Pharmaceuticals LLC
$147
Sunovion Pharmaceuticals Inc.
$144
Allergan, Inc.
$124
Strongbridge US INC.
$122
CATALYST PHARMACEUTICALS, INC.
$121
Janssen Pharmaceuticals, Inc
$102
Bayer HealthCare Pharmaceuticals Inc.
$101
SK Life Science, Inc.
$94
Mitsubishi Tanabe Pharma America, Inc.
$84
Akcea Therapeutics, Inc.
$83
Neurelis, Inc.
$77
Medtronic USA, Inc.
$67
Zogenix Inc.
$66
Amneal Pharmaceuticals LLC
$56
Xeris Pharmaceuticals, Inc.
$51
LivaNova USA, Inc.
$49
ARGENX US, INC.
$44
BANNER LIFE SCIENCES, LLC
$44
IMPEL PHARMACEUTICALS INC.
$40
Greenwich Biosciences, Inc.
$38
Mylan Pharmaceuticals Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
GE HEALTHCARE
$37
MITSUBISHI TANABE PHARMA AMERICA, INC.
$35
Kedrion Biopharma Inc.
$33
Nevro Corp.
$33
Otsuka America Pharmaceutical, Inc.
$32
TG THERAPEUTICS, INC.
$24
Octapharma USA, Inc.
$24
Bausch Health US, LLC
$24
ASSERTIO THERAPEUTICS, Inc.
$20
Mallinckrodt LLC
$20
JAZZ PHARMACEUTICALS INC.
$19
Averitas Pharma Inc.
$19
Kyowa Kirin, Inc.
$18
Biohaven Pharmaceutical Holding Company Ltd.
$17
UPSHER-SMITH LABORATORIES LLC
$15
Promius Pharma LLC
$14
Aucta Pharmaceuticals, Inc.
$14
Exeltis, USA Inc.
$13
Banner Life Sciences, LLC
$13
Egalet US Inc
$12
Impax Laboratories, Inc.
$11
Zyla Life Sciences
$11
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · DISEASE STATE · DUOPA · Duopa · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · Epidiolex · Equetro · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gammaked · Gamunex-C · Glatiramer Acetate · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Omnia · Ongentys · PANZYGA · PIPELINE-MS · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUTENZA · RADICAVA · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · XARELTO · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in MI.
Geographic Context
Neurologists within 10 mi
356
Per 100K population
28.0
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Warra is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with speaking/promotional industry engagement in the top 7% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Warra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Warra performed 641 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Warra receive payments from pharmaceutical companies?
Yes. Dr. Warra received a total of $136,462 from 80 companies across 1,555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Warra's costs compare to other neurologists in Farmington Hills?
Dr. Warra's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Warra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Farmington Hills
Browse neurologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology